OpenEvidence chief Daniel Nadler says he envisions changing the company’s ad-supported model, which has kept it free for medical professionals and driven its widespread adoption.
Share
Add NBC News to Google
May 13, 2026, 11:30 AM GMT+2
By Jared Perlo
Doctors across America are rapidly adopting OpenEvidence, a free AI-powered chatbot that relies on peer-reviewed literature to answer medical questions. But its CEO, Daniel Nadler, says the model that made OpenEvidence ubiquitous — free for doctors, paid for by ads from pharmaceutical companies and others — may not be the one that the company wants to take into the future.
65% of U.S. doctors reportedly use OpenEvidence, which is supported in part by pharmaceutical ads.
OpenEvidence, an AI-powered medical search tool, has become a fast friend to America’s doctors and is now used by nearly…
OpenAI announces ads in ChatGPT for free and Go tier users, reversing CEO Sam Altman's anti-ads stance as the AI giant confronts…
Rather than chase enterprise contracts with large hospital systems, Freed has focused on small clinics and solo practitioners.
The AI ad wars have officially begun, and OpenAI is staffing up and dropping rates to lure brands away from the likes of Meta and…
Launch of free and more transparent AI systems marks departure from group’s subscription-based closed approach
